Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders' (Deficiency) Equity (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Statements of Changes in Shareholders' (Deficiency) Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2022 $ 144,328 $ (141,351) $ 2,977
Balance, shares at Dec. 31, 2022 310,494      
Share based compensation 222 222
Net loss (4,386) (4,386)
Issuance of common shares pursuant to at-the-market registered offering, net of issuance costs of $19 102 102
Issuance of common shares pursuant to at-the-market registered offering, net of issuance costs, shares 7,942      
Balance at Mar. 31, 2023 144,652 (145,737) (1,085)
Balance, shares at Mar. 31, 2023 318,436      
Balance at Dec. 31, 2023 156,905 (154,218) 2,687
Balance, shares at Dec. 31, 2023 1,547,042      
Issuance of warrants upon settlement of placement agent warrant obligation 154 154
Issuance of common shares upon exercise of warrants net of financing fees of $504 $ 1 2,267 2,268
Issuance of common shares upon exercise of warrants net of financing fees, shares 3,663,834      
Share based compensation 71 71
Net loss (2,113) (2,113)
Balance at Mar. 31, 2024 $ 1 $ 159,397 $ (156,331) $ 3,067
Balance, shares at Mar. 31, 2024 5,210,876